113 related articles for article (PubMed ID: 15704651)
1. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
[TBL] [Abstract][Full Text] [Related]
2. Morphometric angiogenesis parameters for indolent and aggressive non-Hodgkin's lymphoma.
Kopic E; Cickusic E; Kopic A; Arnautovic-Custovic A; Halilbasic A; Tinjic L; Hasic S; Simendic V
Med Arh; 2011; 65(1):9-12. PubMed ID: 21534443
[TBL] [Abstract][Full Text] [Related]
3. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
[TBL] [Abstract][Full Text] [Related]
5. Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.
; Kataria SP; Malik S; Yadav R; Kapil R; Sen R
J Lab Physicians; 2021 Mar; 13(1):22-28. PubMed ID: 34149231
[No Abstract] [Full Text] [Related]
6. Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia.
Mazur G; Haloń A; Wróbel T; Urbaniak J; Kuliczkowski K; Woźniak M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():76-8. PubMed ID: 15638381
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
9. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
10. Increased vascularization predicts favorable outcome in follicular lymphoma.
Koster A; van Krieken JH; Mackenzie MA; Schraders M; Borm GF; van der Laak JA; Leenders W; Hebeda K; Raemaekers JM
Clin Cancer Res; 2005 Jan; 11(1):154-61. PubMed ID: 15671540
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density.
Aggarwal D; Srivastava G; Gupta R; Pant L; Krishan G; Singh S
ISRN Hematol; 2012; 2012():943089. PubMed ID: 22536524
[TBL] [Abstract][Full Text] [Related]
12. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment.
Kreuter M; Kropff M; Fischaleck A; Junker K; Gerss J; Heinecke A; Lindermann M; Reinmuth N; Berdel WE; Mesters RM; Thomas M
Eur Respir J; 2009 Jun; 33(6):1383-8. PubMed ID: 19213790
[TBL] [Abstract][Full Text] [Related]
14. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
15. Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes.
Mazur G; Haloń A; Wróbel T; Kuliczkowski K
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():73-5. PubMed ID: 15638380
[TBL] [Abstract][Full Text] [Related]
16. Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis.
Ranieri G; Patruno R; Lionetti A; Di Summa A; Mattioli E; Bufo P; Pellecchia A; Ribatti D; Zizzo N
Leuk Lymphoma; 2005 Nov; 46(11):1639-43. PubMed ID: 16236617
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications.
Korkolopoulou P; Thymara I; Kavantzas N; Vassilakopoulos TP; Angelopoulou MK; Kokoris SI; Dimitriadou EM; Siakantaris MP; Anargyrou K; Panayiotidis P; Tsenga A; Androulaki A; Doussis-Anagnostopoulou IA; Patsouris E; Pangalis GA
Leukemia; 2005 Jun; 19(6):894-900. PubMed ID: 15800675
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
19. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
[TBL] [Abstract][Full Text] [Related]
20. Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma.
Singh P; Tahlan A; Mohan H; Singh R
J Lab Physicians; 2023 Jun; 15(2):282-288. PubMed ID: 37323605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
